Receiving Grade A Recommendations for Injectable PrEP and New Agents

EP: 1.Common Barriers to PrEP Therapy

EP: 2.Improving Access and Adherence to PrEP

EP: 3.The Value of PrEP as HIV Prevention

EP: 4.How to Select the Right Type of PrEP for Patients

EP: 5.A New Approval in the PrEP Therapeutic Landscape

EP: 6.Understanding the Benefits of Multiple Options for PrEP Therapy

EP: 7.Identifying the Right Patient for Injectable PrEP

EP: 8.Knowing the Ins and Outs of Injectable PrEP

EP: 9.Utilizing Data for Policies and Cost-Effectiveness of PrEP Agents

Now Viewing

EP: 10.Receiving Grade A Recommendations for Injectable PrEP and New Agents

EP: 11.The Social Determinants Affecting PrEP Use and Access

EP: 12.Enhancing Patient Education on PrEP Therapies

EP: 13.Future Opportunities to Improve PrEP Access and Management

Lynne H. Milgram, MD, MBA, CPE: The updated guidelines from the US Preventive Services Task Force pointed out a few important things. The most startling [update] talked about making sure you discuss prophylaxis for HIV with all sexually active patients. That’s a good thing, to not single out any group and not take for granted groups that don’t need it. One of the most amazing things about the guidelines is that you used to see direct-to-consumer commercials on TV singling out groups. You only saw 1 group depicted. It’s important. That was a big change.

[The updated guidelines] also pointed out the groups that could benefit from a long-acting injectable. Among them were patients who have problems taking pills, patients who prefer getting an injection every 2 months, and patients who have complications that won’t allow them to take oral medication, such as chronic kidney disease. That in and of itself is a big change, and providers need to be aware of it. In California, where I live, we’ve never had cost-sharing. I work in managed care, which could be different, but it’s a very positive move to not have cost-sharing in this prophylactic area or with treatment. It’s very important. It’s probably less important to me because we never did, but I’m happy that it now exists, at least in California, and I’m sure it does in other health systems such as mine.

Transcript edited for clarity.